We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors Q4 Earnings Miss Estimates, Sales Dip Y/Y
Read MoreHide Full Article
Key Takeaways
IFF posted Q4 adjusted EPS of 80 cents, missing estimates, as sales declined 6.6% y/y.
IFF's Taste sales rose 2.1%, while Scent sales increased 5.5% in the quarter.
International Flavors expects 2026 sales of $10.5B-$10.8B and adjusted EBITDA of $2.05B-$2.15B.
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of 80 cents per share in fourth-quarter 2025, missing the Zacks Consensus Estimate of 85 cents. The company posted adjusted EPS of 93 cents in the year-ago quarter, including the impacts of divestiture and integration-related costs, and other non-recurring costs. Excluding these, the company posted an adjusted EPS of 97 cents in the fourth quarter of 2024.
Including one-time items, the company reported earnings of 7 cents per share against the prior-year quarter’s loss of 23 cents.
International Flavors’ net sales were $2.59 billion in the December-end quarter, down 6.6% from the year-ago quarter. The top line surpassed the Zacks Consensus Estimate of $2.51 billion. In the quarter, currency-neutral sales inched up 1%, aided by mid-single-digit growth in Health & Biosciences and Scent, and a low-single-digit performance in Taste.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
International Flavors’ Q4 Gross Margin Improves Y/Y
In the reported quarter, IFF’s cost of goods sold was down 5.1% year over year to $1.7 billion. Gross profit fell 9.1% to $891 million. The gross margin came in at 34.4% compared with 35.4% in the year-ago quarter.
Research and development expenses increased 2.4% year over year to $174 million. Selling and administrative expenses rose 12.8% to $383 million in the fourth quarter. Adjusted operating EBITDA came in at $437 million, up 7.2% from the prior-year quarter’s $471 million. The adjusted operating EBITDA margin was 16.9% compared with the year-ago quarter’s 17%.
IFF’s Q4 Segmental Performances
Net sales in the Taste segment increased 2.1% year over year to $588 million in the December-end quarter. The figure surpassed our estimate of $572 million. The adjusted operating EBITDA was $94 million, up 8% year over year. Our estimate for the segment’s adjusted EBITDA was $113 million.
Net sales in the Food Ingredients segment fell 2.1% year over year to $802 million in the December-end quarter. The figure beat our estimate of $797 million. The adjusted operating EBITDA was $82 million, up 18% year over year. Our estimate for the segment’s adjusted EBITDA was $98 million.
Sales generated in the Health & Bioscience segment were $586 million compared with the year-earlier quarter’s $555 million. Our estimate was $542 million. The adjusted operating EBITDA was $155 million in the quarter, up 14% year over year. Our estimate for the segment’s adjusted EBITDA was $131 million.
The Scent segment’s sales were $610 million, up 5.5% year over year. Our projection was $567 million. The adjusted operating EBITDA remained flat year over year at $106 million. Our model had projected EBITDA of $107 million.
International Flavors’ Q4 Cash Flow & Balance Sheet Updates
IFF had cash and cash equivalents of $590 million at the end of 2025, up from $469 million at the end of 2024. Long-term debt was $4.74 billion at the 2025 end compared with $7.56 billion at the end of 2024.
International Flavors generated $0.85 billion in cash from operating activities in 2025, down from $1.07 billion in the prior year.
IFF’s 2025 Performance
The company reported adjusted earnings of $4.20 per share in 2025, missing the Zacks Consensus Estimate of $4.28. The company posted adjusted earnings of $4.22 in 2024. Including one-time items, the company reported a loss of $1.46 per share against the prior year’s earnings of $1.04.
International Flavors’ net sales were $10.89 billion in 2025, down 5.2% year over year. The top line surpassed the Zacks Consensus Estimate of $10.82 billion. In the year, currency-neutral sales rose 2%. The upside was driven by volume growth, productivity gains and favorable net pricing.
International Flavors’ 2026 Guidance
The company expects sales for fiscal 2026 between $10.5 billion and $10.8 billion. Adjusted EBITDA is expected between $2.05 billion and $2.15 billion.
IFF Stock’s Price Performance
In the past year, the company’s shares have lost 7% against the industry’s growth of 3.5%.
Performance of Other Chemical - Specialty Stocks in Q3
Linde plc (LIN - Free Report) reported fourth-quarter 2025 adjusted earnings per share of $4.20, which surpassed the Zacks Consensus Estimate of $4.18. The bottom line also improved from the year-ago quarter’s $3.97.
Linde’s sales of $8.76 billion surpassed the Zacks Consensus Estimate of $8.56 billion. The top line also increased from the year-ago quarter’s $8.28 billion.
PPG Industries, Inc.’s (PPG - Free Report) fourth-quarter 2025 adjusted earnings per share were $1.51, down from $1.61 in the year-ago quarter, missing the Zacks Consensus Estimate of $1.57.
PPG Industries’ sales were $3.91 billion in the quarter, up 5% year over year. The top line beat the Zacks Consensus Estimate of $3.74 billion.
Ecolab Inc.’s (ECL - Free Report) adjusted earnings in fourth-quarter 2025 were $2.08 per share, up from $1.81 a year ago. The figure beat the Zacks Consensus Estimate of $2.06.
Ecolab reported sales of $4.196 billion for the quarter, beating the Zacks Consensus Estimate of $4.193 billion. The company’s top line increased 4.8% year over year.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
International Flavors Q4 Earnings Miss Estimates, Sales Dip Y/Y
Key Takeaways
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of 80 cents per share in fourth-quarter 2025, missing the Zacks Consensus Estimate of 85 cents. The company posted adjusted EPS of 93 cents in the year-ago quarter, including the impacts of divestiture and integration-related costs, and other non-recurring costs. Excluding these, the company posted an adjusted EPS of 97 cents in the fourth quarter of 2024.
Including one-time items, the company reported earnings of 7 cents per share against the prior-year quarter’s loss of 23 cents.
International Flavors’ net sales were $2.59 billion in the December-end quarter, down 6.6% from the year-ago quarter. The top line surpassed the Zacks Consensus Estimate of $2.51 billion. In the quarter, currency-neutral sales inched up 1%, aided by mid-single-digit growth in Health & Biosciences and Scent, and a low-single-digit performance in Taste.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
International Flavors & Fragrances Inc. price-consensus-eps-surprise-chart | International Flavors & Fragrances Inc. Quote
International Flavors’ Q4 Gross Margin Improves Y/Y
In the reported quarter, IFF’s cost of goods sold was down 5.1% year over year to $1.7 billion. Gross profit fell 9.1% to $891 million. The gross margin came in at 34.4% compared with 35.4% in the year-ago quarter.
Research and development expenses increased 2.4% year over year to $174 million. Selling and administrative expenses rose 12.8% to $383 million in the fourth quarter. Adjusted operating EBITDA came in at $437 million, up 7.2% from the prior-year quarter’s $471 million. The adjusted operating EBITDA margin was 16.9% compared with the year-ago quarter’s 17%.
IFF’s Q4 Segmental Performances
Net sales in the Taste segment increased 2.1% year over year to $588 million in the December-end quarter. The figure surpassed our estimate of $572 million. The adjusted operating EBITDA was $94 million, up 8% year over year. Our estimate for the segment’s adjusted EBITDA was $113 million.
Net sales in the Food Ingredients segment fell 2.1% year over year to $802 million in the December-end quarter. The figure beat our estimate of $797 million. The adjusted operating EBITDA was $82 million, up 18% year over year. Our estimate for the segment’s adjusted EBITDA was $98 million.
Sales generated in the Health & Bioscience segment were $586 million compared with the year-earlier quarter’s $555 million. Our estimate was $542 million. The adjusted operating EBITDA was $155 million in the quarter, up 14% year over year. Our estimate for the segment’s adjusted EBITDA was $131 million.
The Scent segment’s sales were $610 million, up 5.5% year over year. Our projection was $567 million. The adjusted operating EBITDA remained flat year over year at $106 million. Our model had projected EBITDA of $107 million.
International Flavors’ Q4 Cash Flow & Balance Sheet Updates
IFF had cash and cash equivalents of $590 million at the end of 2025, up from $469 million at the end of 2024. Long-term debt was $4.74 billion at the 2025 end compared with $7.56 billion at the end of 2024.
International Flavors generated $0.85 billion in cash from operating activities in 2025, down from $1.07 billion in the prior year.
IFF’s 2025 Performance
The company reported adjusted earnings of $4.20 per share in 2025, missing the Zacks Consensus Estimate of $4.28. The company posted adjusted earnings of $4.22 in 2024. Including one-time items, the company reported a loss of $1.46 per share against the prior year’s earnings of $1.04.
International Flavors’ net sales were $10.89 billion in 2025, down 5.2% year over year. The top line surpassed the Zacks Consensus Estimate of $10.82 billion. In the year, currency-neutral sales rose 2%. The upside was driven by volume growth, productivity gains and favorable net pricing.
International Flavors’ 2026 Guidance
The company expects sales for fiscal 2026 between $10.5 billion and $10.8 billion. Adjusted EBITDA is expected between $2.05 billion and $2.15 billion.
IFF Stock’s Price Performance
In the past year, the company’s shares have lost 7% against the industry’s growth of 3.5%.
International Flavors’ Zacks Rank
IFF currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Performance of Other Chemical - Specialty Stocks in Q3
Linde plc (LIN - Free Report) reported fourth-quarter 2025 adjusted earnings per share of $4.20, which surpassed the Zacks Consensus Estimate of $4.18. The bottom line also improved from the year-ago quarter’s $3.97.
Linde’s sales of $8.76 billion surpassed the Zacks Consensus Estimate of $8.56 billion. The top line also increased from the year-ago quarter’s $8.28 billion.
PPG Industries, Inc.’s (PPG - Free Report) fourth-quarter 2025 adjusted earnings per share were $1.51, down from $1.61 in the year-ago quarter, missing the Zacks Consensus Estimate of $1.57.
PPG Industries’ sales were $3.91 billion in the quarter, up 5% year over year. The top line beat the Zacks Consensus Estimate of $3.74 billion.
Ecolab Inc.’s (ECL - Free Report) adjusted earnings in fourth-quarter 2025 were $2.08 per share, up from $1.81 a year ago. The figure beat the Zacks Consensus Estimate of $2.06.
Ecolab reported sales of $4.196 billion for the quarter, beating the Zacks Consensus Estimate of $4.193 billion. The company’s top line increased 4.8% year over year.